Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Dermacen analytica: A novel methodology integrating multi-modal large language models with machine learning in dermatology
25
Zitationen
4
Autoren
2025
Jahr
Abstract
OBJECTIVE: To design, implement, evaluate, and quantify a novel and adaptable Artificial Intelligence-empowered methodology aimed at supporting a dermatologist's workflow in assessing and diagnosing skin conditions, leveraging AI's deep image analytic power and reasoning. Skin presents diverse conditions that no single AI solution can comprehensively address, suggesting that mimicking a medical professional's diagnostic process and creating strategic AI interventions may enhance decision-making. PATIENTS AND METHODS: We employ large language, transformer-based vision models for image analysis, sophisticated machine learning tools for guideline-based segmentation, and measuring tasks in our system. As no single technology is sufficient on its own for efficient use by dermatologists, we apply a sequential logic with agency to improve outcomes. RESULTS: Using natural language processing methods and incorporating human expert evaluation, our system achieved a weighted accuracy of 87% on the dataset used, demonstrating its reasoning and diagnostic capabilities. CONCLUSIONS: This study serves as a proof of concept for the application of AI in dermatology, highlighting its potential to enhance the patient journey for which we approximate the value of such interventions in healthcare using graph theory with an associated cost-optimization objective function.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.516 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.113 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.675 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.811 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.364 Zit.